FDA Submits Collection of Information for OMB Review

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its efforts to comply with the International Conference on Harmonisation E2C(R2) guidance on post-market periodic safety reports.